| Bioactivity | 19-[(β-D-Glucopyranosyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide, the metabolite of Neoandrographolide, inhibits nitric oxide (NO) production in lipopolysaccharide-activated macrophages[1]. |
| Name | 19-[(β-D-Glucopyranosyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide |
| CAS | 919120-78-8 |
| Formula | C26H38O9 |
| Molar Mass | 494.57 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yixiong Wang, et al. Microbial transformation of neoandrographolide by Mucor spinosus (AS 3.2450). Journal of Molecular Catalysis B: Enzymatic. Volume 68, Issue 1, January 2011, Pages 83-88. |
19-[(β-D-Glucopyranosyl)oxy]-19-oxo-ent-labda-8(17),13-dien-16,15-olide
CAS: 919120-78-8 F: C26H38O9 W: 494.57
19--19-oxo-ent-labda-8(17),13-dien-16,15-olide, the metabolite of Neoandrographolide, inhibits nitric oxide (NO) product
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.